{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:07:10Z","timestamp":1791112030126,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pacific Alzheimer Research Foundation"},{"name":"Jack Brown and Family Alzheimer's Disease Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.neuropharm.2012.05.033","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T21:21:49Z","timestamp":1338412909000},"page":"685-691","source":"Crossref","is-referenced-by-count":57,"title":["Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers"],"prefix":"10.1016","volume":"63","author":[{"given":"Sadayuki","family":"Hashioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andis","family":"Klegeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.05.033_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijdevneu.2010.08.001","article-title":"Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics","volume":"29","author":"Babu","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/nrc.1011","article-title":"NADPH-diaphorase activity in the frontal cortex of NBM-lesioned rats treated with verapamil","volume":"28","author":"Caballero-Bleda","year":"2001","journal-title":"Neurosci. Res. Comm."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ajmg.b.31122","article-title":"L-type calcium channels and psychiatric disorders: a brief review","volume":"153B","author":"Casamassima","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib4","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/00004872-199917121-00009","article-title":"Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells","volume":"17","author":"Cominacini","year":"1999","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4318\/tjg.2009.0004","article-title":"Effects of verapamil, sodium nitroprusside and glutathione addition into perfusion\/preservation solutions on preservation-related ICAM-1 molecule expression in rat liver","volume":"20","author":"Dalgic","year":"2009","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.2916127","article-title":"Nimodipine facilitates associative learning in aging rabbits","volume":"243","author":"Deyo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0306-4522(01)00528-0","article-title":"Altered expression of voltage-dependent calcium channel alpha(1) subunits in temporal lobe epilepsy with Ammon's horn sclerosis","volume":"111","author":"Djamshidian","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib8","doi-asserted-by":"crossref","first-page":"C327","DOI":"10.1152\/ajpcell.1998.275.2.C327","article-title":"Ion channels in microglia (brain macrophages)","volume":"275","author":"Eder","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF02246077","article-title":"Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells","volume":"121","author":"Fang","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2012.05.033_bib10","doi-asserted-by":"crossref","first-page":"233S","DOI":"10.1111\/j.1365-2125.1985.tb02809.x","article-title":"The molecular pharmacology and structural features of calcium channels","volume":"20","author":"Ferry","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1018592215557","article-title":"Nimodipine maintains in\u00a0vivo the increase in GFAP and enhances the astroglial ensheathment of surviving motoneurons in the rat following permanent target deprivation","volume":"26","author":"Guntinas-Lichius","year":"1997","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(00)00296-7","article-title":"Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine","volume":"101","author":"Harkany","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib13","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.neurobiolaging.2008.02.019","article-title":"Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells","volume":"30","author":"Hashioka","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2010.04.023","article-title":"Differential expression of interferon-gamma receptor on human glial cells in\u00a0vivo and in\u00a0vitro","volume":"225","author":"Hashioka","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.nbd.2010.09.018","article-title":"STAT3 inhibitors attenuate interferon-gamma-induced neurotoxicity and inflammatory molecule production by human astrocytes","volume":"41","author":"Hashioka","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/glia.21157","article-title":"Proton pump inhibitors reduce interferon-gamma-induced neurotoxicity and STAT3 phosphorylation of human astrocytes","volume":"59","author":"Hashioka","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1291\/hypres.23.521","article-title":"The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells","volume":"23","author":"Hayashi","year":"2000","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0306-4522(00)00101-9","article-title":"Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia","volume":"98","author":"Hegg","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neurobiolaging.2004.06.012","article-title":"Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous system","volume":"26","author":"Klegeris","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WCO.0b013e3280adc943","article-title":"Therapeutic approaches to inflammation in neurodegenerative disease","volume":"20","author":"Klegeris","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(95)00825-B","article-title":"Verapamil treatment attenuates immunoreactive GFAP at cerebral cortical lesion site","volume":"695","author":"Klepper","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neures.2005.04.008","article-title":"Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25\u201335)-induced neurotoxicity in cultured rat cortical cells","volume":"52","author":"Lee","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuropharm.2008.10.016","article-title":"Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation","volume":"56","author":"Li","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2010.10.002","article-title":"Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation","volume":"60","author":"Liu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(96)12492-7","article-title":"High affinity block by nimodipine of the internal calcium elevation in chronically depolarized rat cerebellar granule neurons","volume":"207","author":"Marchetti","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3171\/jns.1999.90.4.0760","article-title":"Nimodipine-induced improved survival rate of facial motor neurons following intracranial transection of the facial nerve in the adult rat","volume":"90","author":"Mattsson","year":"1999","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2010-1219","article-title":"Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy","volume":"19","author":"McGeer","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00207459708986392","article-title":"Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer's disease in rats","volume":"92","author":"Popovic","year":"1997","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00207459708986375","article-title":"Open field behavior in nucleus basalis magnocellularis-lesioned rats treated with physostigmine and verapamil","volume":"91","author":"Popovic","year":"1997","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1520-6769(199807\/08)23:1<13::AID-NRC2>3.0.CO;2-O","article-title":"Effect of acute physostigmine and verapamil treatment on aggressive and depressive behavior in rats with lesioned nucleus basalis magnocellularis","volume":"23","author":"Popovic","year":"1998","journal-title":"Neurosci. Res. Comm."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00221-005-0219-3","article-title":"Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis","volume":"170","author":"Popovic","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib32","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.STR.26.10.1888","article-title":"Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia","volume":"26","author":"Roda","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/physiolgenomics.00064.2002","article-title":"Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays","volume":"11","author":"Sarang","year":"2002","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-2008-13402","article-title":"Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders","volume":"13","author":"Schwab","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib35","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1016\/j.biomaterials.2010.07.039","article-title":"Tailoring the efficacy of nimodipine drug delivery using nanocarriers based on A2B miktoarm star polymers","volume":"31","author":"Soliman","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.neuropharm.2012.05.033_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","article-title":"Calcium channel antagonists: clinical uses \u2013 past, present and future","volume":"74","author":"Triggle","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-5728(97)00124-0","article-title":"Paraneoplastic anti-Hu serum: studies on human tumor cell lines","volume":"79","author":"Verschuuren","year":"1997","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2012.05.033_bib38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.1994.62010372.x","article-title":"Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture","volume":"62","author":"Weiss","year":"1994","journal-title":"J.\u00a0Neurochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:52:52Z","timestamp":1617619972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0028390812002316"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.033","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}